Skip to main content
Advertisement
Advertisement
IRWD
IRWD logo
Ironwood Pharmaceuticals, Inc. - Class A
3.61
USD
Sponsored
+0.10
+2.85%
Oct 28, 15:59 UTC -4
Closed
exchange

After-Market

3.61

0.00
0.00%

Ironwood Pharmaceuticals, Inc. - Class A (IRWD) Earnings

IRWD Earnings Reports

Positive Surprise Ratio

IRWD beat 21 of 42 last estimates.

50%

Next Report

Tomorrow
Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$124.00M
/
$0.32
Implied change from Q2 26 (Revenue/ EPS)
+9.69%
/
+3.23%
Implied change from Q3 25 (Revenue/ EPS)
+1.59%
/
+33.33%

Ironwood Pharmaceuticals, Inc. - Class A earnings per share and revenue

On Aug 06, 2026, IRWD reported earnings of 0.31 USD per share (EPS) for Q2 26, missing the estimate of 0.36 USD, resulting in a -14.62% surprise. Revenue reached 113.04 million, compared to an expected 117.14 million, with a -3.50% difference. The market reacted with a +2.65% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.32 USD, with revenue projected to reach 124.00 million USD, implying an increase of 3.23% EPS, and increase of 9.69% in Revenue from the last quarter.
FAQ
For Q2 2026, Ironwood Pharmaceuticals, Inc. - Class A reported EPS of $0.31, missing estimates by -14.62%, and revenue of $113.04M, -3.5% below expectations.
The stock price moved up 2.65%, changed from $4.15 before the earnings release to $4.26 the day after.
The next earning report is scheduled for Oct 29, 2026.
Based on 4 analysts, Ironwood Pharmaceuticals, Inc. - Class A is expected to report EPS of $0.32 and revenue of $124.00M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement